Skip to main content

Events

Art and Science Collided in Frederick’s Latest Art Display

A new collaboration between the Frederick National Laboratory for Cancer Research (FNLCR) and the Frederick Arts Council recently showcased the intersection between science and art. The Frederick Arts Council’s latest art exhibit, “Where Energy Meets Matter: Exploring the Frontiers of Science,” invited artists to explore the dynamic interplay of art and science and celebrate the cutting-edge research and innovation happening at FNLCR and throughout Frederick.

Biotech Connector Reimagines the Future of Gene and Cell Therapies

The recent Biotech Connector showcased exciting advancements in gene and cell therapies in the Frederick area. More than 80 attendees gathered in-person and online to hear experts in the field discuss their work manufacturing difficult therapies for clinical trials, reimagining the supply chain to reduce development timelines, and leveraging automation to reduce risk and save money. By capturing these advances, the Biotech Connector aims to serve as a forum that inspires partnerships and the sharing of ideas.

28th Spring Research Festival Swells with Attendance, Enthusiasm

It’s three minutes before the keynote at the 2025 Spring Research Festival, and the seats are filling up. Chatter thrums through the room. Somewhere within the stir, someone is talking about tumors. A voice at the back keeps mentioning malaria. Like the whirl of hushed conversations, the burgeoning audience is an amalgam.

OHS Marks Heart Month with Lunch-Hour Cook-off and Health Webinar

This February saw Occupational Health Services host two lunch-hour activities to encourage employees to invest in cardiovascular health and healthy living. The 18th Chili Cook-off occurred on February 7, and a Heart Health Webinar occurred on February 12. Both coincided with American Heart Month.

Progress against RAS-driven cancers lauded at RAS Symposium, with more candidate treatments on the horizon

Researchers from around the world met in October to mark progress their field has made in developing drugs to treat cancers driven by the RAS oncogene, and to map out even more ways they can help cancer patients. “This is a great story about tackling an intractable disease that was said to be an impossible task,” said National Cancer Institute Director W. Kimryn Rathmell, M.D.